Madutide (also known as research code IBI362) is a novel dual-agonist drug primarily used to treat obesity and type 2 diabetes. Its mechanism of action involves simultaneously activating two key hormone receptors in the body:
1. GLP-1 Receptor Agonist
● Appetite Suppression: Activates brain receptors to reduce hunger and increase satiety.
● Slows Gastric Emptying: Delays gastric emptying, prolonging postprandial satiety.
● Glycoglycemic Control: Stimulates insulin release in a glucose-dependent manner and inhibits glucagon (a hormone that raises blood sugar).
● Weight Loss: Promotes fat reduction and may improve cardiovascular health.
2. GIP Receptor Agonist
● Enhanced Metabolic Effects: Glucose-dependent insulinotropic peptides (GIPs) complement GLP-1 by:
○ Increasing the sensitivity of adipose tissue to insulin.
○ Reducing fat storage and promoting lipid metabolism.
○ Potentially preserving pancreatic β-cell function.
● Synergistic effect with GLP-1: GIP receptor activation can enhance the weight loss and metabolic benefits of GLP-1 when used alone.
Key advantages compared to single agonists
Madutide's dual mechanism of action leverages the complementary effects of the GLP-1 and GIP pathways, resulting in:
● Greater weight loss (15-22% compared to placebo in Phase 3 trials).
● Improved glycemic control and insulin sensitivity.
● Potentially fewer side effects (e.g., nausea) compared to some GLP-1-only drugs.
Clinical status
● Approved in China for weight management (September 2023).
● Undergoing global Phase 3 clinical trials for obesity and type 2 diabetes.
● Weekly subcutaneous injection (similar to smegglutide or telapatetide).
Why dual action is important
Drugs like madutide and telapatetide represent a shift towards multi-target therapies in the treatment of metabolic diseases. Madutide, by simultaneously activating the GLP-1 and GIP pathways, is designed to provide superior efficacy in weight loss and metabolic health compared to earlier medications.
For personalized advice, consult a healthcare professional. Always use prescription medications as directed by your doctor.
Whatsapp: ＋85246360786
sararaws128@gmail.com